AXA Investment Managers’s Exact Sciences EXAS Stock Holding History

AXA Investment Managers’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$28.6M	Buy	+521,983	New	+$26.1M	0.08%	226

Other funds holding EXAS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AXA Investment Managers's EXAS Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Exact Sciences (EXAS) in Q3 2025: 521,983 shares worth $28.6M. The stake represents 0.08% of the portfolio and ranks #226 among its holdings.

567 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.

AXA Investment Managers held 521,983 shares of Exact Sciences worth $28.6M as of Q3 2025.
Exact Sciences was a new AXA Investment Managers position in Q3 2025.
Exact Sciences made up 0.08% of AXA Investment Managers's portfolio in Q3 2025, its #226 holding.
567 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.